SORT-AF Supervised Obesity Reduction Trial for AF Ablation Patients (SORT-AF)

Prospective randomized multicenter study to evaluate the impact of weight reduction on AF recurrence after AF ablation in obese patients. A 1:1 randomisation for 6-month intensive medical attendance with nutrition advice and physical training following atrial fibrillation ablation vs. usual care (atrial fibrillation ablation without therapy of obesity) shall lead to evidence for reversibility of negative influences of obesity in atrial fibrillation. A subcutaneous event recorder will be implanted before ablation to detect all possible episodes of atrial fibrillation after ablation therapy.

SORT-AF - SORT-AF Supervised Obesity Reduction Trial for AF Ablation Patients (SORT-AF)

Publications

Supervised Obesity Reduction Trial for AF Ablation Patients: Results from the SORT-AF trial. Gessler, N. et al. Europace. 2021, Apr 25;euab122. doi: 10.1093/europace/euab122. https://pubmed.ncbi.nlm.nih.gov/33895833/

Principal Investigators

Stephan Willems (Hamburg), Daniel Steven (Köln)

Study information
SORT-AF

Recruiting status
Study completed
Recruitment start
01.2014
Patients
140
140
Clinical Trials Registration

NCT02064114

German Clinical Trials Register

Deutsches Register für Klinische Studien

Category
Guideline relevant study
DZHK Funding
DZHK-assoziierte Studie (keine finanzielle Förderung)

Operative contact Nele Geßler, MD
n.gessler@asklepios.com